Organoids: Stunt Doubles for Human Organs

organoid

The pursuit of new drugs to treat and cure human diseases is one of the noblest things in our civilization. However, 6 out of 10 drugs fail during the clinical trials, making the lengthy and expensive R&D process a proverbial double-edged sword. High rates of failure are often attributed to the poor predictability of 2D […]

Read More…

Science Exchange Adds Allergan EVP & Chief R&D Officer David Nicholson to Its Board of Directors

board-of-directors

PALO ALTO CA, June 27, 2018 — Science Exchange, Inc. announced today that C. David Nicholson, Ph.D., EVP and Chief R&D Officer at Allergan, has joined the Science Exchange Board of Directors. Dr. Nicholson’s experience includes over forty years in research and development in the pharmaceutical industry spanning senior leadership roles at Allergan, Bayer CropScience, Schering-Plough, […]

Read More…

Q&A with LI-COR

licor-q-a

Guru Singh, Director of Scientific Content of Science Exchange, recently spoke with Jim Wiley, Director of Marketing, Biotechnology at LI-COR Biosciences. Follow the interview below. What should Science Exchange users know about LI-COR? We are committed to making research reproducible. To illustrate, LI-COR is the only company that has developed methods required by journals and […]

Read More…